Hippo pathway found essential to orchestrate the development of the heart

April 23, 2018, Baylor College of Medicine
Dr. James Martin. Credit: Baylor College of Medicine

Using a technology that provides a 'high-resolution view' of the status of individual cells, a team of researchers has gained new insights into the embryonic development of the mouse heart. They discovered that during development, when progenitor heart cells progressively differentiate into various cell types, the Hippo pathway is essential to coordinate the development of these cell types into a working heart. The study appears in the journal Developmental Cell.

"The Hippo is known for its role as an inhibitor of adult heart regeneration," said corresponding author Dr. James Martin, professor of molecular physiology and biophysics and Vivian L. Smith Chair in Regenerative Medicine at Baylor College of Medicine. "If you take the Hippo pathway away, then the heart can regenerate."

In this study, Martin and his colleagues asked whether the Hippo pathway also was involved in the of the heart. Specifically, they investigated the role the pathway played in regulating the of a group of cardiac progenitor called epicardial cells. During development and heart injury, these cells become essential supporters of the cardiomyocytes, the beating muscle cells of the heart.

The researchers genetically engineered mice to lack two essential components of the Hippo pathway, and then determined how the hearts developed when compared with those of normal mice. Martin and his colleagues looked at the structure of the heart and also analyzed nearly 18,200 cells taken from heart tissue during a period of development.

The Hippo pathway is essential for normal heart development

The hearts of the mice with a defective Hippo pathway were smaller than normal hearts. Unexpectedly, was also defective; blood vessel coverage was reduced and less dense. These and other results suggested that the Hippo pathway is required for normal heart and blood vessel development.

"In addition, we analyzed thousands of cells from developing heart tissue with a technology called single cell transcriptomics," said Martin, who also is director of the Cardiomyocyte Renewal Lab at the Texas Heart Institute. "This technology allowed us to determine the status of thousands of cells individually. For instance, we learned what genes were turned on and what molecules the cells were expressing. This high level of detail shed light into the cellular and molecular processes leading to an adult heart and how they are coordinated."

The researchers learned of a number of genes and pathways they had not thought would be linked to the Hippo pathway during the heart's embryonic development, for instance, the retinoic acid or vitamin A pathway. They also discovered that when the Hippo pathway is defective during the heart's embryonic development, cardiac fibroblasts do not advance through their normal developmental program.

"We found cells suspended in intermediate states and producing factors important for regulating growth and proliferation of ," Martin said. "That was all unexpected."

These new insights suggest that during heart development, when cells progress through transition states, the Hippo pathway regulates the production of factors that regulate normal growth of vascular endothelial cells. Importantly, the Hippo pathway plays an essential role in this process, much like an 'orchestra director' coordinating the development of several types of cells in the heart.

"We know that the Hippo pathway is involved in regeneration of the adult heart, but also controls the size of the developing heart," Martin said. "As the heart grows, more vascular cells need to move into the heart to provide blood vessels to sustain its growth and later support the function of the adult heart. We think that the Hippo pathway can sense the size of the growing heart and, by regulating a number of secreted factors, determine how many cardiac fibroblasts and endothelial cells develop in the heart."

Martin and his colleagues are applying these findings to better understand regeneration of the adult heart.

"If we can figure out ways to improve the blood vessels' ability to regenerate in the adult heart, we would open new possibilities to improve the treatment of disease in the future," Martin said.

Explore further: Scientists reverse advanced heart failure in an animal model

More information: Yang Xiao et al, Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development, Developmental Cell (2018). DOI: 10.1016/j.devcel.2018.03.019

Related Stories

Scientists reverse advanced heart failure in an animal model

October 4, 2017
Researchers have discovered a previously unrecognized healing capacity of the heart. In a mouse model, they were able to reverse severe heart failure by silencing the activity of Hippo, a signaling pathway that can prevent ...

Research reveals new insights into why the heart does not repair itself

June 5, 2017
Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart disease is the leading cause of death for both men and women in the United States, according to the Centers for Disease ...

Breakthrough in adult heart repair

November 19, 2013
Researchers from the Baylor College of Medicine and the Texas Heart Institute have discovered a new way to dramatically improve heart repair. The future goal is to use this knowledge to combat human cardiovascular disease ...

A pathway controlling inflammatory responses aids recovery after heart attack

February 6, 2017
After a heart attack, or myocardial infarction, a patient's long-term prognosis depends on the ability of the heart tissue to heal and remodel. Immune system activation and inflammatory responses that occur in the aftermath ...

Study maps molecular mechanisms crucial for new approach to heart disease therapy

February 13, 2018
Creating new healthy heart muscle cells within a patient's own ailing heart. This is how scientists hope to reverse heart disease one day. Today, a new study led by UNC-Chapel Hill researchers reveals key molecular details ...

Scientists use color-coded tags to discover how heart cells develop

February 22, 2018
UCLA researchers used fluorescent colored proteins to trace how cardiomyocytes—cells in heart muscle that enable it to pump blood—are produced in mouse embryos. The findings could eventually lead to methods for regenerating ...

Recommended for you

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.